SE454566B - Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus - Google Patents
Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotusInfo
- Publication number
- SE454566B SE454566B SE8402238A SE8402238A SE454566B SE 454566 B SE454566 B SE 454566B SE 8402238 A SE8402238 A SE 8402238A SE 8402238 A SE8402238 A SE 8402238A SE 454566 B SE454566 B SE 454566B
- Authority
- SE
- Sweden
- Prior art keywords
- water
- krill
- pharmaceutical composition
- effect
- enzymes
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims description 19
- 108091005804 Peptidases Proteins 0.000 title claims description 13
- 102000035195 Peptidases Human genes 0.000 title claims description 13
- 229930184510 Mallotus Natural products 0.000 title claims description 5
- 241001060384 Mallotus <angiosperm> Species 0.000 title claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 title claims 5
- 210000004051 gastric juice Anatomy 0.000 claims description 22
- 235000013372 meat Nutrition 0.000 claims description 16
- 210000000577 adipose tissue Anatomy 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 235000019833 protease Nutrition 0.000 claims description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 8
- 108090001060 Lipase Proteins 0.000 claims description 6
- 102000004882 Lipase Human genes 0.000 claims description 6
- 239000004367 Lipase Substances 0.000 claims description 6
- 235000019421 lipase Nutrition 0.000 claims description 6
- 239000008188 pellet Substances 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 239000003613 bile acid Substances 0.000 claims description 5
- 230000000968 intestinal effect Effects 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 3
- 239000003833 bile salt Substances 0.000 claims description 2
- 229940093761 bile salts Drugs 0.000 claims description 2
- 238000000354 decomposition reaction Methods 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 44
- 239000000203 mixture Substances 0.000 abstract description 42
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 1
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 abstract 1
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract 1
- 229910052759 nickel Inorganic materials 0.000 abstract 1
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical class S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052815 sulfur oxide Inorganic materials 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 66
- 108090000790 Enzymes Proteins 0.000 description 66
- 229940088598 enzyme Drugs 0.000 description 66
- 241000239366 Euphausiacea Species 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 230000001079 digestive effect Effects 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 22
- 238000000034 method Methods 0.000 description 19
- 239000000284 extract Substances 0.000 description 16
- 230000029087 digestion Effects 0.000 description 14
- 230000004580 weight loss Effects 0.000 description 12
- 230000004584 weight gain Effects 0.000 description 11
- 235000019786 weight gain Nutrition 0.000 description 11
- 210000001198 duodenum Anatomy 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 241001417902 Mallotus villosus Species 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 6
- 230000002797 proteolythic effect Effects 0.000 description 6
- 210000003296 saliva Anatomy 0.000 description 6
- 229910000679 solder Inorganic materials 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 102000013142 Amylases Human genes 0.000 description 5
- 108010065511 Amylases Proteins 0.000 description 5
- 235000019418 amylase Nutrition 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 208000035467 Pancreatic insufficiency Diseases 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 229940079919 digestives enzyme preparation Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 108010019160 Pancreatin Proteins 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 229940055695 pancreatin Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000239370 Euphausia superba Species 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 208000002310 Achlorhydria Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 208000000668 Chronic Pancreatitis Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000212918 Euphausia crystallorophias Species 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000212925 Meganyctiphanes norvegica Species 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108010071195 Nucleotidases Proteins 0.000 description 1
- 102000007533 Nucleotidases Human genes 0.000 description 1
- 206010033649 Pancreatitis chronic Diseases 0.000 description 1
- 108010057825 Pankreon Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- -1 depaddurette Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Catalysts (AREA)
- Enzymes And Modification Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Exhaust Gas Treatment By Means Of Catalyst (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8402238A SE454566B (sv) | 1984-04-24 | 1984-04-24 | Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus |
| EP85902209A EP0177605B1 (de) | 1984-04-24 | 1985-04-24 | Eine enzymzusammensetzung als verdauungsbeschleuniger bei verschiedenen spiegeln im verdauungskanal und deren herstellungsverfahren |
| PCT/SE1985/000187 WO1985004809A1 (en) | 1984-04-24 | 1985-04-24 | An enzyme composition acting as a digestion promotor on various levels in the alimentary tract, and a method for facilitating digestion |
| JP60501951A JPH0657659B2 (ja) | 1984-04-24 | 1985-04-24 | 消化管にて種々のレベルで消化促進剤として作用する酵素組成物 |
| US06/829,642 US4695457A (en) | 1984-04-24 | 1985-04-24 | Enzyme composition acting as a digestion promoter on various levels in the alimentary tract, and a method for facilitating digestion |
| DE8585902209T DE3585865D1 (de) | 1984-04-24 | 1985-04-24 | Eine enzymzusammensetzung als verdauungsbeschleuniger bei verschiedenen spiegeln im verdauungskanal und deren herstellungsverfahren. |
| AT85902209T ATE74765T1 (de) | 1984-04-24 | 1985-04-24 | Eine enzymzusammensetzung als verdauungsbeschleuniger bei verschiedenen spiegeln im verdauungskanal und deren herstellungsverfahren. |
| US07/069,705 US4780445A (en) | 1984-04-24 | 1987-06-30 | Selective catalytic reduction catalyst consisting essentially of nickel and/or manganese sulfate, ceria and alumina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8402238A SE454566B (sv) | 1984-04-24 | 1984-04-24 | Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8402238D0 SE8402238D0 (sv) | 1984-04-24 |
| SE8402238L SE8402238L (sv) | 1985-10-25 |
| SE454566B true SE454566B (sv) | 1988-05-16 |
Family
ID=20355656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8402238A SE454566B (sv) | 1984-04-24 | 1984-04-24 | Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US4695457A (de) |
| EP (1) | EP0177605B1 (de) |
| JP (1) | JPH0657659B2 (de) |
| AT (1) | ATE74765T1 (de) |
| DE (1) | DE3585865D1 (de) |
| SE (1) | SE454566B (de) |
| WO (1) | WO1985004809A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE456245B (sv) * | 1986-07-09 | 1988-09-19 | Pharmacia Ab | Enzympreparation innehallande krillhyaluronidas |
| SE8703064D0 (sv) * | 1987-08-06 | 1987-08-06 | Viggo Mohr | Method for isolating active enzyme preparations from animal tissues |
| AU618962B2 (en) * | 1987-08-06 | 1992-01-16 | Aktiebolaget L.H. Forskning | Method for the isolation of active enzyme(s) from krill tissue |
| SE8801701D0 (sv) * | 1988-05-05 | 1988-05-05 | Pharmacia Ab | Production technology based on enzymic method |
| NO164844C (no) * | 1988-10-24 | 1990-11-21 | Norsk Hydro As | Fremgangsmaate ved utvinning av enzymer fra krepsdyr. |
| CN1060793A (zh) * | 1990-10-22 | 1992-05-06 | 华东化工学院 | 非贵金属三效催化剂 |
| US5445957A (en) * | 1994-02-10 | 1995-08-29 | Triarco Industries, Inc. | Enzyme food supplement composition containing beta-fructofuranosidase, cellulase and hemicellulase |
| JP3678335B2 (ja) * | 1998-05-18 | 2005-08-03 | 株式会社日本触媒 | 低級アルカン酸化脱水素用触媒およびオレフィンの製造方法 |
| JP2003502071A (ja) * | 1999-06-18 | 2003-01-21 | ブジャーナソン・ヨーン・ブラーギ | 魚類セリンプロティナーゼ及びそれらの薬品及び化粧品への利用 |
| US20030059356A1 (en) * | 1999-11-30 | 2003-03-27 | Engelhard Corporation | Catalyst material aging method |
| US6436267B1 (en) * | 2000-08-29 | 2002-08-20 | Applied Materials, Inc. | Method for achieving copper fill of high aspect ratio interconnect features |
| ATE295737T1 (de) * | 2000-11-02 | 2005-06-15 | Cilian Ag | Verwendung von aus ciliaten gewonnenen enzymen als verdauungsfördernde arzneimittel |
| WO2004056985A2 (ja) * | 2002-12-19 | 2004-07-08 | Nippon Suisan Kaisha, Ltd. | オキアミ粗酵素液の製法、その粗酵素液とその凍結品、およびそれらを用いた飼料 |
| RU2278681C1 (ru) * | 2005-01-24 | 2006-06-27 | Открытое акционерное общество "Нижегородский химико-фармацевтический завод" | Средство для лечения заболеваний предстательной железы |
| US8115373B2 (en) | 2005-07-06 | 2012-02-14 | Rochester Institute Of Technology | Self-regenerating particulate trap systems for emissions and methods thereof |
| JP5326251B2 (ja) * | 2007-10-02 | 2013-10-30 | マツダ株式会社 | 排気ガス浄化触媒装置 |
| GB201501081D0 (en) | 2015-01-22 | 2015-03-11 | Cilian Ag | Use of enzymes with a wide pH activity range as medicaments for promoting digestion |
| EP3121272A1 (de) | 2015-07-24 | 2017-01-25 | Zymetech ehf. | Neuartige fischtrypsinisoformen und deren verwendung |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB377128A (en) * | 1931-03-11 | 1932-07-21 | H Th Boehme Ag | A process for the production of ferment preparations |
| US2503313A (en) * | 1947-04-14 | 1950-04-11 | Levin Ezra | Production of dried, defatted enzymatic material |
| FR1015566A (fr) * | 1948-04-15 | 1952-10-15 | Heviferm Lab G M B H | Procédé d'obtention de préparations stables de ferments, sous une quantité dosable, à partir d'intestins de poissons de mer ou d'eau douce et d'autres animaux aquatiques |
| GB1053702A (de) * | 1963-04-25 | 1900-01-01 | ||
| FR3071M (fr) * | 1963-10-18 | 1965-01-18 | Centre Nat Rech Scient | Nouvelles protéases pancréatiques, utilisables notamment en gastro-entérologie. |
| US3803304A (en) * | 1965-07-19 | 1974-04-09 | Armour Pharma | Orally administratable pancreatic enzymes and methods of using same |
| US3956483A (en) * | 1968-10-24 | 1976-05-11 | Wilson Pharmaceutical & Chemical Corporation | Preparing pancreatin |
| US4107272A (en) * | 1973-05-21 | 1978-08-15 | Hitachi, Ltd. | Process for removing nitrogen oxides using ammonia as a reductant and sulfated metallic catalysts |
| CA1047422A (en) * | 1974-02-21 | 1979-01-30 | Hans Betzing | Process of manufacturing enzyme preparation rich in lipase |
| DE2554515A1 (de) * | 1975-12-04 | 1977-06-08 | Volkmar Dr Kose | Widerstandslegierung fuer tiefe temperaturen mit einstellbarem temperaturkoeffizienten |
| US4088539A (en) * | 1976-05-07 | 1978-05-09 | A. Nattermann & Cie Gmbh | Process of manufacturing enzyme preparation rich in lipase |
| JPS52156168A (en) * | 1976-06-22 | 1977-12-26 | Mitsubishi Chem Ind Ltd | Waste gas treatment of nitric acid plant |
| GB1561613A (en) * | 1977-04-14 | 1980-02-27 | Biorex Laboratories Ltd | Pharmaceutical oral dosage forms containing pancreatin |
| US4331565A (en) * | 1980-11-28 | 1982-05-25 | General Motors Corporation | Method for forming high surface area catalyst carrier and catalyst using same |
| AU573730B2 (en) * | 1982-10-25 | 1988-06-23 | Antarctic Pharma Ab | Enzyme composition from euphausiaceae (antarctic krill) as cleaning agent |
-
1984
- 1984-04-24 SE SE8402238A patent/SE454566B/sv not_active IP Right Cessation
-
1985
- 1985-04-24 JP JP60501951A patent/JPH0657659B2/ja not_active Expired - Lifetime
- 1985-04-24 AT AT85902209T patent/ATE74765T1/de not_active IP Right Cessation
- 1985-04-24 WO PCT/SE1985/000187 patent/WO1985004809A1/en not_active Ceased
- 1985-04-24 EP EP85902209A patent/EP0177605B1/de not_active Expired
- 1985-04-24 DE DE8585902209T patent/DE3585865D1/de not_active Expired - Fee Related
- 1985-04-24 US US06/829,642 patent/US4695457A/en not_active Expired - Lifetime
-
1987
- 1987-06-30 US US07/069,705 patent/US4780445A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61501918A (ja) | 1986-09-04 |
| DE3585865D1 (de) | 1992-05-21 |
| EP0177605A1 (de) | 1986-04-16 |
| US4695457A (en) | 1987-09-22 |
| SE8402238D0 (sv) | 1984-04-24 |
| SE8402238L (sv) | 1985-10-25 |
| WO1985004809A1 (en) | 1985-11-07 |
| US4780445A (en) | 1988-10-25 |
| ATE74765T1 (de) | 1992-05-15 |
| JPH0657659B2 (ja) | 1994-08-03 |
| EP0177605B1 (de) | 1992-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE454566B (sv) | Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus | |
| DE69634248T2 (de) | Zusammensetzungen zur verbesserung der verdaulichkeit und ausnutzung von nähestoffen | |
| EP0107634B1 (de) | Enzymzusammensetzung zum Reinigen, deren Anwendung und Herstellung der Zusammensetzung | |
| US20080292610A1 (en) | Medicaments containing enzymes from ciliates for promoting digestion in digestive disorders | |
| NZ527148A (en) | Novel mixtures of microbial enzymes | |
| NO832399L (no) | Trombolytisk middel | |
| KR960011522B1 (ko) | 리파아제 및 리파아제 추출물, 그들의 제조방법 및 이를 함유한 지방물질 흡수기능장애 치료용 약제 | |
| CA2251009C (fr) | Medicament optimisant la viscosite des mucus et stimulant le fonctionnement de l'intestin | |
| Grossman | The physiology of secretin | |
| DE69918152D1 (de) | Behandlung von verdauungsstörungen | |
| Lurie et al. | Pancreatic exocrine responses to test meals of varying compositions in man | |
| JPS61500431A (ja) | 傷治癒に有用な活性化され、安定化された酵素 | |
| JP4695629B2 (ja) | 難消化剤 | |
| JP2014051473A (ja) | 血糖上昇抑制組成物 | |
| Perrie et al. | Electrophoretic study of the small subunits of the myosin molecule | |
| JPH0124134B2 (de) | ||
| JP2000080043A (ja) | 水溶性ビタミンｋ剤 | |
| JPS59199633A (ja) | ガン細胞、菌、蛇毒をラツカ−ゼを主体とする漆の夾雑物に浸漬保存して成る免疫剤 | |
| NO142105B (no) | Fremgangsmaate til fremstilling av et stabilt enzym- og hormonkompleks fra tynntarmer | |
| NO165093B (no) | Enzymsammensetning for rensing, bruken av den og framstilling av sammensetningen. | |
| KR20030067752A (ko) | 미생물 효소의 신규 혼합물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8402238-3 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8402238-3 Format of ref document f/p: F |